These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1478337

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Product development of probiotics as biological drugs.
    Sutton A.
    Clin Infect Dis; 2008 Feb 01; 46 Suppl 2():S128-32; discussion S144-51. PubMed ID: 18181718
    [Abstract] [Full Text] [Related]

  • 23. Quality of biotechnological products: analysis of the expression construct in cell lines used for production of r-DNA derived protein products. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998 Feb 01; 93():205-8. PubMed ID: 9737397
    [No Abstract] [Full Text] [Related]

  • 24. Adventitious agents from animal-derived raw materials and production systems.
    Hellman KB, Honstead JP, Vincent CK.
    Dev Biol Stand; 1996 Feb 01; 88():231-4. PubMed ID: 9119142
    [No Abstract] [Full Text] [Related]

  • 25. Cell line issues: historical and future perspectives.
    Petricciani JC.
    Dev Biol Stand; 1992 Feb 01; 76():5-11. PubMed ID: 1478355
    [Abstract] [Full Text] [Related]

  • 26. Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov 07; 65(216):66621-35. PubMed ID: 11503696
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. An overview of animal cell substrates for biological products.
    Petricciani J, Sheets R.
    Biologicals; 2008 Nov 07; 36(6):359-62. PubMed ID: 18674929
    [Abstract] [Full Text] [Related]

  • 29. Medical devices of human origin.
    Williams D.
    Med Device Technol; 2001 Apr 07; 12(3):8, 10-1. PubMed ID: 11547687
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Review of current preclinical testing strategies for bacterial vaccines.
    Falk LA, Chandler DK, Richman P.
    Dev Biol Stand; 1998 Apr 07; 95():25-9. PubMed ID: 9855411
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Introduction to the issues: detection of retroviruses and associated risks.
    Marcus-Sekura CJ.
    Dev Biol Stand; 1992 Apr 07; 76():137-40. PubMed ID: 1478334
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Statistical bases for defining level of assurance.
    Schofield T.
    Dev Biol (Basel); 2006 Apr 07; 123():209-16; discussion 217-22. PubMed ID: 16566447
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.